search
Back to results

Knee Arthroplasty Activity Trial (KArAT)

Primary Purpose

Knee Osteoarthritis, Total Knee Replacement

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Telephonic Active Coaching (Motivational Interviewing) + Financial Incentives
Wrist based activity tracker wear
Basic Study Activities
Sponsored by
Brigham and Women's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Physical Activity, Total Knee Replacement, Knee Osteoarthritis

Eligibility Criteria

40 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 40-85 years
  • English-speaking
  • Scheduled to undergo primary, unilateral total knee replacement (TKR) at one of the 5 recruitment centers
  • OA is principal underlying indication for TKR
  • During an accelerometer run-in period lasting one week at baseline (prior to surgery), subjects must show that they can comply with wrist-worn and waist-worn physical activity tracker protocols: (1) subject wears both activity trackers for ≥4/7 days of the week for ≥10 hours/day, (2) subject uploads wrist-worn activity tracker data and returns waist-worn activity tracker after accelerometer run-in period
  • Regular access to a personal computer, laptop, tablet, or smartphone for wrist-worn activity tracker syncing
  • Average baseline steps/day (calculated from waist-worn activity tracker data from the run-in period)<5,000

Exclusion Criteria:

  • Non-English speaking
  • Residence in nursing home
  • Diagnosis of dementia, epilepsy, Parkinson's Disease, or diabetes with peripheral neuropathy
  • Inflammatory arthritis (rheumatoid arthritis, reactive arthritis, systemic lupus erythematosus, polymyalgia)
  • Psychological issues that preclude participation
  • Inpatient or other musculoskeletal surgery scheduled within six months following index primary TKR
  • Surgeon-documented other reason for study exclusion

Sites / Locations

  • Northwestern Memorial HospitalRecruiting
  • University of Kansas Medical CenterRecruiting
  • Brigham and Women's HospitalRecruiting
  • University at BuffaloRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Other

Experimental

Experimental

Arm Label

Arm1

Arm2

Arm3

Arm Description

Participants in this arm receive usual post-operative care and complete all basic study activities, which include: attending 2 in-clinic visits at designated time-points, having regular check-in calls with study staff over the intervention period, wearing and returning waist-worn activity trackers at 5 time points over two years, and completing 6 study surveys.

Participants in this arm receive usual post-operative care, complete all basic study activities (as described in arm 1) and receive the wrist-based activity tracker intervention.

Participants in this arm receive usual post-operative care, complete all basic study activities (as described in arm 1), receive wrist-based activity tracker intervention, and receive the TAC(MI)+FI.

Outcomes

Primary Outcome Measures

Proportion of Subjects Engaged in at least 150 min/week of moderate-to-vigorous physical activity (MVPA).
The primary outcome of this trial is the proportion of subjects who meet or surpass the PA threshold of 150 minutes per week of at least moderate physical activity, which is defined as 3 metabolic equivalents (METs), at 32-weeks post-TKR.

Secondary Outcome Measures

Change in average daily step count
Change in subjects' average daily step count from pre-TKR to 32-weeks post-TKR as measured by the ActiGraph.
Change in weekly minutes of moderate-to-vigorous activity (MVPA)
Change in the number of minutes per week that subjects spend engaged in MVPA from pre-TKR to 32-weeks post-TKR as measured by the ActiGraph.
Change in average daily sedentary time
Change in subjects' daily sedentary time from pre-TKR to 32-weeks post-TKR as measured by the ActiGraph.

Full Information

First Posted
September 24, 2019
Last Updated
August 17, 2023
Sponsor
Brigham and Women's Hospital
Collaborators
Northwestern Memorial Hospital, University of Kansas Medical Center, University at Buffalo
search

1. Study Identification

Unique Protocol Identification Number
NCT04107649
Brief Title
Knee Arthroplasty Activity Trial
Acronym
KArAT
Official Title
Knee Arthroplasty Activity Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 27, 2023 (Actual)
Primary Completion Date
June 15, 2028 (Anticipated)
Study Completion Date
June 15, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital
Collaborators
Northwestern Memorial Hospital, University of Kansas Medical Center, University at Buffalo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Total knee replacement (TKR) is a common and costly procedure widely used to relieve pain and improve function in patients with symptomatic advanced knee osteoarthritis (OA). As of 2013, the annual incidence of TKR was over 680,000 surgeries and annual costs exceeded $11 billion. Growing evidence suggests that while pain and functional status improve following TKR, physical activity (PA) typically does not surpass pre-TKR levels. Engagement in PA can meaningfully improve quality of life (QoL), pain, and function. Given the large investment in TKR, the effectiveness and cost-effectiveness of TKR could be substantially increased if TKR recipients became more physically active. The Knee Arthroplasty Activity Trial (KArAT) is a randomized controlled trial and participants will be randomly assigned to one of three arms. Participants across all arms will receive usual post-operative care for TKR surgery. Participants in the first arm will complete basic study activities, such as responding to surveys and attending two in-person clinic visits. Participants in the second arm will do the same and also receive a wrist-based physical activity tracker intervention. Participants in the third arm will receive a telephonic active coaching (motivational interviewing) and financial incentives (for reaching physical activity goals) (TAC(MI)+FI) based intervention, as well as a wrist-based physical activity tracker intervention. The second and third arms will be eligible to receive lottery-based financial rewards for wearing a wrist-worn activity tracker for twenty-four months during the study.
Detailed Description
The investigators have designed the KArAT trial with two specific aims. First, to conduct a parallel three-arm RCT to establish the efficacy and sustainability of the effect of personalized intervention built on the principles of behavioral science and behavioral economics in improving PA among sedentary people who have undergone TKR. Our second aim is to establish the cost-effectiveness and budget impact of TAC(MI)+FI to improve PA in persons who have undergone TKR. The three arms will include: Arm 1: Usual post-TKR care Arm 2: Usual post-TKR care + Wrist-based physical activity tracker wear Arm 3: Usual post-TKR care + Wrist-based physical activity tracker wear + Telephonic Active Coaching (Motivational Interviewing) + Financial Incentives (TAC(MI)+FI).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis, Total Knee Replacement
Keywords
Physical Activity, Total Knee Replacement, Knee Osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Three arm parallel randomized control trial.
Masking
Care ProviderInvestigatorOutcomes Assessor
Masking Description
The investigators, care providers, and outcomes assessors will not be appraised of treatment arm.
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Arm1
Arm Type
Other
Arm Description
Participants in this arm receive usual post-operative care and complete all basic study activities, which include: attending 2 in-clinic visits at designated time-points, having regular check-in calls with study staff over the intervention period, wearing and returning waist-worn activity trackers at 5 time points over two years, and completing 6 study surveys.
Arm Title
Arm2
Arm Type
Experimental
Arm Description
Participants in this arm receive usual post-operative care, complete all basic study activities (as described in arm 1) and receive the wrist-based activity tracker intervention.
Arm Title
Arm3
Arm Type
Experimental
Arm Description
Participants in this arm receive usual post-operative care, complete all basic study activities (as described in arm 1), receive wrist-based activity tracker intervention, and receive the TAC(MI)+FI.
Intervention Type
Behavioral
Intervention Name(s)
Telephonic Active Coaching (Motivational Interviewing) + Financial Incentives
Other Intervention Name(s)
TAC(MI)+FI
Intervention Description
As part of TAC(MI)+FI, participants speak with a health coach at Brigham and Women's Hospital once a week via telephone for weeks 6-13 following surgery, and once every other week for weeks 14-31 after surgery. Participants in this arm can receive financial rewards for achieving weekly physical activity goals, as well as bonus rewards for achieving goals multiple weeks in a row. Over the course of this 6-month long TAC(MI)+FI intervention period, these participants are able to receive up to $680 for meeting physical activity goals, and up to $95 in bonus rewards.
Intervention Type
Behavioral
Intervention Name(s)
Wrist based activity tracker wear
Intervention Description
Activity tracking data will be collected on a weekly basis. Participants who receive this intervention are eligible to be entered into a lottery to win one of two $25 rewards for every week they wear their wrist-based activity tracker >10 hours for >4/7 days a week, beginning 6-weeks after surgery.
Intervention Type
Other
Intervention Name(s)
Basic Study Activities
Intervention Description
Basic study activities begin two-weeks before TKR and end approximately 24-months after TKR. Basic study activities include: two in-person visits at the local clinic site (2 weeks before TKR and 32-weeks after TKR), having check-in calls with study staff weekly from weeks 1-13 after surgery and every other week for weeks 14-31, completing 6 surveys, and wearing an ActiGraph activity tracker (waist-worn) for five one-week periods throughout the study (2-weeks before-TKR, 32-weeks post-TKR, one-year post-TKR, 18-months post-TKR, two-years post-TKR). All participants will be eligible to receive up to $235 for completing these activities over the course of two years.
Primary Outcome Measure Information:
Title
Proportion of Subjects Engaged in at least 150 min/week of moderate-to-vigorous physical activity (MVPA).
Description
The primary outcome of this trial is the proportion of subjects who meet or surpass the PA threshold of 150 minutes per week of at least moderate physical activity, which is defined as 3 metabolic equivalents (METs), at 32-weeks post-TKR.
Time Frame
32-weeks post-TKR
Secondary Outcome Measure Information:
Title
Change in average daily step count
Description
Change in subjects' average daily step count from pre-TKR to 32-weeks post-TKR as measured by the ActiGraph.
Time Frame
2-week pre-TKR to 32-weeks post-TKR
Title
Change in weekly minutes of moderate-to-vigorous activity (MVPA)
Description
Change in the number of minutes per week that subjects spend engaged in MVPA from pre-TKR to 32-weeks post-TKR as measured by the ActiGraph.
Time Frame
2 week pre-TKR to 32-weeks post-TKR
Title
Change in average daily sedentary time
Description
Change in subjects' daily sedentary time from pre-TKR to 32-weeks post-TKR as measured by the ActiGraph.
Time Frame
2 weeks pre-TKR to 32-weeks post-TKR
Other Pre-specified Outcome Measures:
Title
Durability of changes in activity levels
Description
Changes in subjects' activity levels at 12-, 18-, and 24-months post-TKR as measured by the ActiGraph.
Time Frame
2 weeks pre-TKR to 24 months post-TKR
Title
Change in pain and functional status
Description
Change in subjects' pain and functional status at 8-, 12-, 18-, and 24-months post-TKR as measured by the questionnaire.
Time Frame
2 weeks pre-TKR to 24 months post-TKR
Title
Change in quality of life
Description
Change in subjects' quality of life at 8-, 12-, 18-, and 24-months post-TKR as measured by the questionnaire.
Time Frame
2 weeks pre-TKR to 24 months post-TKR
Title
Change in performance measures
Description
Change in subjects' performance at 32 weeks post-TKR as measured by performance tests.
Time Frame
2 weeks pre-TKR to 6 months post-TKR
Title
Change in cost
Description
Change in subjects' medical costs at 8-, 12-, 18-, and 24-months post-TKR as measured by the questionnaire.
Time Frame
2 weeks pre-TKR to 24 months post-TKR

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 40-85 years English-speaking Scheduled to undergo primary, unilateral total knee replacement (TKR) at one of the 4 recruitment centers OA is principal underlying indication for TKR During an accelerometer run-in period lasting one week at baseline (prior to surgery), subjects must show that they can comply with waist-worn physical activity tracker protocols by wearing the activity tracker for ≥4/7 days of the week for ≥10 hours/day Regular access to a personal computer, laptop, tablet, or smartphone for wrist-worn activity tracker syncing Satisfying average baseline steps/day criteria (calculated from waist-worn activity tracker data from the run-in period) Exclusion Criteria: Non-English speaking Residence in nursing home Diagnosis of dementia, epilepsy, Parkinson's Disease, or diabetes with peripheral neuropathy Inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, systemic lupus erythematosus, polymyalgia) Psychological issues that preclude participation Inpatient or other musculoskeletal surgery scheduled within six months following index primary TKR Uses a wheelchair to ambulate (subjects who use a cane will be eligible) Surgeon-documented other reason for study exclusion Subject does not have regular access to a device capable of receiving email or text messages
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elena Losina, Ph.D., MSC
Phone
617-732-5338
Email
elosina@bwh.harvard.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Faith Selzer, Ph.D.
Phone
617-525-8617
Email
fselzer@bwh.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elena Losina, Ph.D.
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Northwestern Memorial Hospital
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marcella Oliver
Phone
312-503-6071
Email
irbreliance@northwestern.edu
First Name & Middle Initial & Last Name & Degree
Rowland Chang, M.D., M.P.H.
Facility Name
University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karen Blackwell
Phone
913-588-0942
Email
kblackwe@kumc.edu
First Name & Middle Initial & Last Name & Degree
Neil Segal, M.D.
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Sundquist
Phone
857-282-1902
Email
msundquist@partners.org
First Name & Middle Initial & Last Name & Degree
Elena Losina, Ph.D., M.Sc.
Facility Name
University at Buffalo
City
Buffalo
State/Province
New York
ZIP/Postal Code
14215
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zachary N Chakan
Phone
716-888-4874
Email
znchakan@buffalo.edu
First Name & Middle Initial & Last Name & Degree
Scott R Nodzo, M.D.

12. IPD Sharing Statement

Learn more about this trial

Knee Arthroplasty Activity Trial

We'll reach out to this number within 24 hrs